Compliance
Who Can Use a Patient’s Photos? Rights Across Clinics, Agencies, and Creators
How Korean clinics and global marketing partners should separate patient consent, image rights, and copyright across international content distribution.

A patient photograph can move from a Korean clinic’s consultation room to an agency’s editing desk, an overseas creator’s account, and a paid campaign. Each transfer introduces a different question about who may use the image, for what purpose, and under whose authority.
The strategic issue is fragmented control. International patient acquisition depends on content moving across languages and organizations, while permission remains tied to particular people, purposes, and uses.
One photograph carries several layers of rights
For clinics marketing Korea as a medical destination, a signed release should not be treated as universal clearance. Personal information processing, permission to use someone’s likeness, and copyright in the photograph require separate analysis.
Under Korea’s legal framework, identifiable patient images can raise personal information issues. Their clinical context may also reveal health information, making the circumstances of collection and disclosure particularly important. The Personal Information Protection Act and Medical Service Act provide relevant legal boundaries.
Permission to use a patient’s likeness addresses another question: whether that person has authorized the proposed public presentation. A patient’s agreement to clinical photography does not, by itself, establish permission for international promotional use.
Copyright concerns the photograph as a creative work. Depending on authorship, employment arrangements, and contracts, a clinic commissioning a shoot may still need to establish its rights to reproduce, edit, distribute, or authorize further use.
Table: Separate rights questions attached to a patient photograph
| Rights layer | Central question | Evidence to examine |
|---|---|---|
| Personal information | What permits collection, use, and disclosure? | Processing basis, notices, and consent records where applicable |
| Likeness and public presentation | Has the patient authorized this presentation? | Release terms, approved contexts, and restrictions |
| Copyright | Who may reproduce, adapt, and distribute the work? | Authorship records, licenses, and assignment terms |
These layers can produce different answers for the same image. A clinic might have a photographer’s commercial license while lacking permission for a particular patient-facing campaign, or hold patient permission without sufficient editing rights.

The operating role matters more than the contract label
Agency agreements often describe every content transfer as outsourced work. That description alone does not establish whether a recipient processes information on the clinic’s instructions or receives it for a separate purpose.
The more useful inquiry concerns actual conduct. Who chooses the audience, decides the use, authorizes onward distribution, and benefits from independent reuse? Korean privacy guidance makes the real processing arrangement important when distinguishing entrusted processing from third-party provision.
An agency preparing approved advertisements under a clinic’s instructions presents a different arrangement from a creator obtaining images for an independently managed content business. The distinction becomes more consequential when a recipient retains material for portfolios, unrelated promotions, or future commercial partnerships.
Neither arrangement should be classified from a single fact. Account ownership, editorial freedom, retention practices, and decision-making authority need to be assessed together against the applicable rules.
For hospitals designing an international patient acquisition operation, this makes partner governance part of channel strategy. Distribution capacity has limited value when the hospital cannot explain which organization controls each use.
The practical output is a documented allocation of roles. It should identify who instructs whom, which purposes are permitted, whether independent use exists, and what happens when the relationship ends.
Translation and paid promotion can change the authorized use
Content teams often treat translation as a production step. For patient photography, translation can change the audience and the meaning surrounding the image, even when the underlying photograph remains untouched.
A clinical explanation on a Korean-language website may become a short overseas advertisement with a different headline and fewer qualifications. Cropping, sequencing, captions, and voiceovers can all change what viewers understand the photograph to demonstrate.
The analytical question is whether the proposed version remains within the original authorization and lawful processing purpose. A move into another language, account, or paid placement deserves review rather than an assumption that permission automatically travels with the file.
Paid promotion adds another dimension: deliberate amplification to selected audiences. Approval for publication on an identified clinic page should not simply be read as approval for every advertising platform, creator account, or future campaign.
Table: Content changes that warrant a fresh scope review
| Proposed change | What may change | Review focus |
|---|---|---|
| Translation for an overseas audience | Meaning and audience expectations | Accuracy and authorized publication context |
| Cropping or combining photographs | Apparent comparison or clinical implication | Presentation integrity and editing rights |
| Moving into paid advertising | Reach, targeting, and commercial context | Authorized channels and promotional uses |
| Publication through a creator’s account | Publisher, control, and reuse incentives | Recipient role and onward-use restrictions |
A review does not always mean obtaining new consent. It means checking the existing processing basis, permission, and license against the proposed use, then resolving any gap before publication.
This is particularly relevant to multilingual social media marketing. The unit of approval should be the image in its proposed context, including the translated message and placement, rather than an isolated photograph.
Restrictions must reach overseas creators and subcontractors
International distribution frequently involves more parties than the clinic directly appoints. An agency may engage a translator, editor, local media buyer, or creator, each with different systems and retention habits.
A restriction in the clinic’s main agreement has limited operational value if downstream recipients never receive it. Contracts should carry permitted uses, access limits, onward-transfer conditions, and deletion duties through the authorized chain.
Overseas handling also requires a separate assessment of applicable cross-border personal information requirements. A confidentiality clause alone does not settle those requirements, and a foreign recipient’s local obligations may need parallel consideration.
Deletion terms need operational detail. They should address working files, shared folders, scheduled posts, advertising assets, and copies held by approved subcontractors, while recognizing any applicable retention duties.
The parties should also distinguish removal from controlled channels from attempts to address external copies. Contracts can allocate takedown responsibilities, but they should not promise control over every screenshot or unauthorized repost.
Contract termination deserves the same precision. The agreement should explain whether existing publications must be removed, whether campaigns must stop, and which records can be retained for a defined, legitimate purpose.
Distribution records turn withdrawal into an actionable process
A consent document records an authorization; it does not reveal where the photograph subsequently travelled. That gap becomes visible when a patient withdraws consent or a creator partnership ends.
A photograph-level distribution record connects permission to actual use. Useful entries include the asset identifier, authorization version, approved purposes, recipients, published versions, placements, and the person responsible for each release.
The record should connect translated and edited derivatives to their source image. Without that relationship, a team may remove the original while overlooking a cropped advertisement or a creator’s localized version.
Withdrawal requires a fact-specific response under the applicable rules. Teams need to identify affected processing, stop or adjust relevant uses, communicate with recipients, and document any lawful retention rather than assuming every file has the same status.
Korea’s Personal Information Protection Commission and Privacy Portal provide authoritative starting points for understanding processing responsibilities and individual rights. Their guidance should inform the workflow alongside the governing statutes and the particular contracts.
For international hospital marketing, content rights are a continuing control function. The durable advantage is the ability to connect every published patient image to a valid use, an accountable partner, and a workable response when permission or the commercial relationship changes.
FAQ
Can a patient’s public social media post be reused in a clinic advertisement?
Public availability does not establish advertising permission. The clinic should assess personal information requirements, the patient’s likeness permission, and copyright, including rights held by a separate photographer.
Does covering a patient’s eyes remove the privacy issue?
It may not prevent identification. Other facial features, distinctive marks, accompanying text, or contextual information can still identify the patient; assess the complete publication.
What should a clinic do when an agency cannot locate the original authorization?
Pause new uses of the affected image while reconstructing the records. Confirm the processing basis and relevant permissions before resuming distribution, and assess existing placements separately.
Can a creator keep patient photographs in a portfolio after a campaign ends?
Portfolio use needs its own scope assessment. Permission for a clinic campaign should not automatically be treated as permission for the creator’s separate promotion or continued retention.
Does patient permission also clear the advertisement’s medical claims?
No. Permission to use an image does not resolve compliance with applicable medical advertising rules. Review the finished advertisement, including captions and implied claims, separately.


